ProPhase Labs stock hits 52-week low at 0.41 amid sharp decline - MSN
PRPH Stock | USD 0.42 0.03 5.60% |
Under 60% of ProPhase Labs' investor base is looking to short. The analysis of overall sentiment of trading ProPhase Labs stock suggests that many investors are alarmed at this time. ProPhase Labs' investing sentiment shows overall attitude of investors towards ProPhase Labs.
ProPhase |
ProPhase Labs stock hits 52-week low at 0.41 amid sharp decline MSN
Read at news.google.com
ProPhase Labs Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ProPhase Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ProPhase Labs Fundamental Analysis
We analyze ProPhase Labs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProPhase Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProPhase Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
ProPhase Labs is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
ProPhase Labs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProPhase Labs stock to make a market-neutral strategy. Peer analysis of ProPhase Labs could also be used in its relative valuation, which is a method of valuing ProPhase Labs by comparing valuation metrics with similar companies.
Peers
ProPhase Labs Related Equities
INBS | Intelligent Bio | 9.72 | ||||
STIM | Neuronetics | 6.56 | ||||
SERA | Sera Prognostics | 5.72 | ||||
PRPO | Precipio | 2.54 | ||||
SHC | Sotera Health | 1.97 | ||||
BNR | Burning Rock | 1.65 | ||||
XGN | Exagen | 0.74 | ||||
STRR | Star Equity | 0.47 | ||||
BDSX | Biodesix | 0.95 | ||||
DRIO | DarioHealth Corp | 3.02 | ||||
ENZ | Enzo Biochem | 4.76 |
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |